Latest Breaking News On - Pediatric investigation plan - Page 8 : comparemela.com

Pharming Group N.V.: Pharming Group reports financial results for the first quarter of 2022

Revenues increased 7% yoy to $46.6 million Leniolisib launch on track for Q1 2023 following previously announced positive pivotal data Strong cash flow from operations supporting investments

Clover Provides Corporate Update and 2022 Priorities

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Clover Provides Corporate Update and 2022 Priorities

Soligenix Corporate Update Letter - Key Highlights and Upcoming Catalysts

Soligenix Corporate Update Letter - Key Highlights and Upcoming Catalysts - read this article along with other careers information, tips and advice on BioSpace

Soligenix Corporate Update Letter - Key Highlights and Upcoming Catalysts

/PRNewswire/ Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing.